Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

As a biologic reservoir of Mycobacterium tuberculosis (M. tb), one-quarter of the world population is infected with the well-known latent tuberculosis (LTBI). About 5–10% of LTBI patients will progress to active disease in the first years after primary infection and, despite using the recommended tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Débora Leite, Demarqui, Fernanda Manaia, Solcia, Mariana Cristina, de Souza, Paula Carolina, da Silva Maia, Pedro Ivo, Deflon, Victor Marcelo, Pavan, Fernando Rogério
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598318/
https://www.ncbi.nlm.nih.gov/pubmed/36289661
http://dx.doi.org/10.3390/biomedicines10102398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598318/
https://www.ncbi.nlm.nih.gov/pubmed/36289661
http://dx.doi.org/10.3390/biomedicines10102398

Ejemplares similares